Human cancer vaccine shows promise | Pain doctor charged by DOJ in sexual abuse case | FDA recalls manual resuscitators

Researchers at the University of Florida College of Medicine say mRNA technology could "educate" the immune system to identify and attack cancer anywhere in the body. A promising proof-of-concept study using mice was published in Nature Biomedical Engineering.

Ritesh Kalra, MD, allegedly wrote 31,000 opioid prescriptions between 2019 and 2025, many of which were illegitimate. He is accused of inappropriately touching patients in exchange for oxycodone scripts as part of a five-count criminal indictment.

A problem with the B/V filters on SunMed adult resuscitators can cause the devices to malfunction. Due to the high safety risk this poses to patients, the FDA has assigned this recall its most serious designation.

Over 97% of all counties in the U.S. see high or very high levels of consolidation in Medicare Advantage markets, with UnitedHealthcare and Humana owning the most plans nationwide. 

Former Steward Health Care CEO Ralph de la Torre, MD, and other executives are accused in a $1.4 billion legal filing of paying themselves hundreds of millions of dollars in bonuses, despite the health system being insolvent.

Receivers on active glucose monitors manufactured by Dexcom are reportedly failing to send alerts when a patient’s blood sugar levels are dangerously high or low. There have been no deaths linked to the malfunction. 

Current Health—purchased by Best Buy for $400 million in 2021—is set to become an independent company again, with co-founder Christopher McGhee taking over. The electronics retailer appears to be backing away from remote patient monitoring services, shifting its healthcare division's focus to consumer products that improve the lives of seniors.

Confidence in public health entities is spiraling downward in the U.S., and once-revered Washington institutions like the CDC and NIH are among the casualties in serious condition. How to break the negative momentum?

ICAD shareholders filed suit against the transaction last month in New York, claiming financial estimates used in the deal are misleading. 

Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.